Zhou and colleagues showed that the EZH2 inhibitor DZNep and the siRNA against EZH2 decreased MICU1 expression and trigger cytoplasmic Ca2+ accumulation, loss of membrane potential, and changes in mitochondrial proteins involved in cell death in human oral cancer cell lines [191]. The gene discussed is EZH2; the disease is lip and oral cavity carcinoma.